机译:WT1基因表达在FLT3阳性急性髓性白血病中预测分子最小残留疾病评估预测值
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
Univ Udine Azienda Sanitaria Univ Integrata Udine Div Hematol &
Stem Cell Transplantat I-33100;
机译:WT1基因表达在FLT3阳性急性髓性白血病中预测分子最小残留疾病评估预测值
机译:通过WT1 Q-PCR和多参数流式细胞术评估缓解后的最小残留疾病序贯监测可预测复发,并可能有助于应对急性髓性白血病患者的风险适应性治疗
机译:整合后测定,WT1表达作为最小残留病的标志物可预测急性髓细胞性白血病的预后
机译:基因表达和DNA-甲基化型材的整合提高了急性髓鞘白血病中的分子亚型分类
机译:Egr1的丢失在小鼠白血病的发生中起作用,并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
机译:缓解后通过WT1 Q-PCR和多参数流式细胞术评估对最小残留疾病的顺序监测可预测复发并可能有助于应对急性髓性白血病患者的风险适应性治疗
机译:WT1基因表达对移植前分子微小残留病评估在FLT3阳性急性髓细胞白血病中的预测价值